Healtheway and IOD Announce PRISM 6.2 eHealth Exchange Validation

August 12, 2014 09:00 AM Eastern Daylight Time, GREEN BAY, Wis.--Healtheway, the non-profit, public-private collaborative that supports the eHealth Exchange, and IOD Incorporated, a leading provider of integrated health information management (HIM) solutions for hospitals, healthcare systems and clinics, today announced that IOD PRISM 6.2 is now recognized as an eHealth Exchange validated system. As the first HIM HIT vendor to receive validation, IOD’s customers will experience a significantly reduced level of effort and cost associated with onboarding to the eHealth Exchange through the PRISM platform.

The eHealth Exchange is a growing community of exchange partners, who share health information under a common trust framework and set of rules. Healtheway is the non-profit organization that supports the eHealth Exchange, as well as the eHealth Exchange Product Testing Program, which tests conformance to the specifications and underlying health information exchange (HIE) standards required to onboard with the network.

“Healtheway developed the eHealth Exchange Product Testing Program to provide a high level of assurance that the products that earn validation are interoperable with other systems, while conforming to the eHealth Exchange performance specifications,” says Mariann Yeager, CEO of Healtheway. “PRISM 6.2 successfully passed our rigorous set of required conformance tests and IOD’s customers can expect an expedited onboarding process.”

PRISM 6.2 is the core technology utilized by IOD in its release of information product and service offering. As an eHealth Exchange Validated product, PRISM 6.2 users will have efficient access to the eHealth Exchange that simplifies the onboarding process and makes the power of the eHealth Exchange available to IOD’s 2,700 hospitals and clinics. This allows IOD’s customers to be proficiently interoperable with four federal agencies, five states, dozens of Health Information Organizations (HIOs) and health systems, which represent hundreds of hospitals, thousands of providers and millions of patients that are currently part of the network.

“IOD is committed to bringing innovative, efficient and cost effective solutions to our customers,” said George Abatjoglou, CEO of IOD. “As the first HIM HIT vendor to be certified as an eHealth Exchange validated system, we are taking the steps necessary to meet that promise in a way that directly addresses many of the interoperability challenges that exist in healthcare today.”

About IOD Incorporated

IOD, a leading health information management company with more than 30 years of industry experience, combines innovative technologies and services to streamline workflows, maximize productivity and reduce costs for hospitals, healthcare systems and clinics worldwide. As a result, 2,700 healthcare organizations rely on IOD’s PRISM® platform and supporting services to transform and deliver meaningful health information to the right people at the right time in the right format. To learn more about how IOD helps healthcare organizations achieve their operational and financial goals, visit http://www.iodedge.com/.

About Healtheway

Healtheway is a non-profit organization chartered to advance secure, interoperable nationwide health information exchange (HIE). Healtheway currently supports two initiatives: the eHealth Exchange, a rapidly growing community of exchange partners who share information under a common trust framework and a common set of rules; and Carequality, an industry-driven effort to build consensus among existing health IT data exchange programs regarding technical specifications and best practices (similar to when the banking industry created a nationwide ATM network). Healtheway leads in cross-industry collaboration to develop implementation strategies that enable secure, interoperable nationwide exchange of health information. For more information about Healtheway, the eHealth Exchange and Carequality, visit www.healthewayinc.org.

 

Contacts

For IOD Incorporated
Robert Clarke, 770-576-3192
rclarke@dodgecommunications.com

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.